AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Tax Provision
AstraZeneca PLC
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Tax Provision
-$938m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Tax Provision
-£756m
|
CAGR 3-Years
-124%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Tax Provision
-$474k
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Tax Provision
-$4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Tax Provision
-$89m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-1%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Tax Provision
£8.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's Tax Provision?
Tax Provision
-938m
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Tax Provision amounts to -938m USD.
What is AstraZeneca PLC's Tax Provision growth rate?
Tax Provision CAGR 10Y
-3%
The average annual Tax Provision growth rates for AstraZeneca PLC have been -7% over the past three years , and -3% over the past ten years .